The Impact of Intermittent Androgen Suppression Therapy in Prostate Cancer Modeling
Previous studies on prostate cancer modeling under hormonal therapy gildan midnight successfully fit clinical serum androgen data, under the assumption that the levels of intracellular and serum androgen are similar.However, such an assumption may not hold throughout the course of treatment.In this paper, we propose a model that directly accounts f